ResearcherUniversity of InsubriaActive in the last 2 years

Antonino Bruno

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4790-0861; OpenAlex author ID A5023598157. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2026: 1 paper

Papers 1

The TGF-βR1 inhibitor galunisertib re-shapes the PDAC-TME by limiting decidual-like natural killer cells polarization. Last author DOI 10.1038/s41419-026-08581-9 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Andrea Resovi · 1 shared paper, 2026 · strength 0.21
- Paper The TGF-βR1 inhibitor galunisertib re-shapes the PDAC-TME by limiting decidual-like natural killer cells polarization. DOI 10.1038/s41419-026-08581-9 ↗
Dorina Belotti · 1 shared paper, 2026 · strength 0.21
- Paper The TGF-βR1 inhibitor galunisertib re-shapes the PDAC-TME by limiting decidual-like natural killer cells polarization. DOI 10.1038/s41419-026-08581-9 ↗
Gennaro Nappo · 1 shared paper, 2026 · strength 0.21
- Paper The TGF-βR1 inhibitor galunisertib re-shapes the PDAC-TME by limiting decidual-like natural killer cells polarization. DOI 10.1038/s41419-026-08581-9 ↗
Alessandro Zerbi · 1 shared paper, 2026 · strength 0.21
- Paper The TGF-βR1 inhibitor galunisertib re-shapes the PDAC-TME by limiting decidual-like natural killer cells polarization. DOI 10.1038/s41419-026-08581-9 ↗
Martina Cucchiara · 1 shared paper, 2026 · strength 0.21
- Paper The TGF-βR1 inhibitor galunisertib re-shapes the PDAC-TME by limiting decidual-like natural killer cells polarization. DOI 10.1038/s41419-026-08581-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.